Chemours (CC) To Post Q3 Earnings: What's In The Offing?
Zacks Investment Research | Oct 31, 2019 06:06AM ET
The Chemours Company (NYSE:CC) is scheduled to release its third-quarter 2019 results after the bell on Nov 4. The company is likely to have faced some volume pressure in its Titanium Technologies segment in the quarter. Moreover, results in the Fluoroproducts unit are expected to reflect the impact of illegal imports. However, the company is likely to have benefited from continued customer adoption of Opteon refrigerants and its productivity actions.
Chemours missed the Zacks Consensus Estimate for earnings in two of the trailing four quarters while beat once and delivered in-line results on the other occasion. In this timeframe, the company delivered an average negative surprise of around 11.1%.
Chemours’ shares are down around 41.2% year to date, underperforming the industry ’s decline of roughly 20.1%.
Let’s see how things are shaping up for this announcement.
What do the Estimates Say?
The Zacks Consensus Estimate for revenues for the third quarter for Chemours is currently pegged at $1,393 million, reflecting an expected decline of roughly 14.5% on a year over year basis.
Revenues in the Fluoroproducts segment are projected to decline 5% year over year as the Zacks Consensus Estimate for the third quarter is pegged at $648 million.
Moreover, the Zacks Consensus Estimate for revenues for the Chemical Solutions unit for the third quarter stands at $160 million, which reflects an expected 3.2% increase from the prior-year quarter.
Revenues from the Titanium Technologies division are expected to decline 26.7% year over year as the Zacks Consensus Estimate is pegged at $580 million.
Some Factors at Play
Lower volumes are likely to have hurt third-quarter sales in the company’s Titanium Technologies segment. Chemours is seeing pressure on Ti-Pure TiO2 (titanium dioxide) pigment volumes. The company witnessed lower volumes for these products through the first half of 2019 due to weak demand (especially in Europe). The trend is likely to have continued in the third quarter amid a challenging macroeconomic environment.
The company is also facing challenges from illegal imports of HFC refrigerants into the European Union from China. These illegal imports are hurting pricing and volumes of refrigerants. Lower industrial demand, partly due to weakness in the global automotive industry, is also affecting fluoropolymer volumes. These headwinds might reflect on sales in the Fluoroproducts unit in the third quarter.
Get The News You Want
Nevertheless, the company is expected to have benefited from increasing adoption of Opteon refrigerants in the September quarter. Chemours is seeing strong adoption of Opteon for mobile applications. Benefits of the company’s actions to manage costs and drive productivity are also expected to get reflected on third-quarter results.
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.